Precedex contains the active ingredient dexmedetomidine hydrochloride, which is a central alpha-adrenergic agonist. It is available as an intravenous infusion, presented in two formulations: a concentrate for dilution (100 mcg/mL) and a ready-to-use form (4 mcg/mL), both in 0.9% sodium chloride. Key inactive ingredients include sodium chloride and water for injection. Precedex is used to manage patients who require sedation in a hospital setting, as inferred from its class as a central alpha-adrenergic agonist typically used in sedation practices.